Effectiveness of Vitamin A in the Prevention of Complications of Prematurity
Conclusion Given the increased risk of sepsis in patients weighing >1000 g, the risk associated with repeated intramuscular injections of vitamin A and the modest clinical results described, we do not believe the universal administration of vitamin A to VLBW infants to be justified as prophylaxis for bronchopulmonary dysplasia.
Source: Pediatrics and Neonatology - Category: Perinatology & Neonatology Source Type: research
More News: Bronchopulmonary Dysplasia | Pediatrics | Perinatology & Neonatology | Study | Vitamin A | Vitamins